# Odyssey Therapeutics, Inc.: filings

ODTX · Nasdaq · CIK 1882782 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/odtx.md) · [Financials](/companies/odtx/financials.md) · [Filings](/companies/odtx/filings.md) · [Insiders](/companies/odtx/insiders.md)

## Reports and events: 15 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (3 19, 4 15, 8-K 6, D 4, DRS/A 4, SCHEDULE 13D 4, 10-Q 2, DRS 2, S-1 2, SCHEDULE 13G 2, 424B4 1, 8-A12B 1, CERT 1, D/A 1, EFFECT 1, RW 1, S-1/A 1, S-1MEF 1, S-8 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-20 | 11:00 ET | [8-K](/filings/0001193125-26-425684.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-425684 |
| 2026-09-09 | 23:10 ET | [8-K](/filings/0001193125-26-385477.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-385477 |
| 2026-08-06 | 23:00 ET | [10-Q](/filings/0001193125-26-335822.md) | Quarterly report, period 2026-06-30 | 0001193125-26-335822 |
| 2026-08-04 | 11:00 ET | [8-K](/filings/0001193125-26-331512.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-331512 |
| 2026-06-23 | 12:45 ET | [8-K](/filings/0001193125-26-278581.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-278581 |
| 2026-06-17 | 20:45 ET | [10-Q](/filings/0001193125-26-274290.md) | Quarterly report, period 2026-03-31 | 0001193125-26-274290 |
| 2026-06-17 | 20:45 ET | [8-K](/filings/0001193125-26-274291.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-274291 |
| 2026-05-18 | 22:29 ET | [SCHEDULE 13D](/filings/0001072613-26-000468.md) | Ownership report, active investor | 0001072613-26-000468 |
| 2026-05-18 | 20:06 ET | [SCHEDULE 13D](/filings/0001999371-26-011002.md) | Ownership report, active investor | 0001999371-26-011002 |
| 2026-05-15 | 20:08 ET | [SCHEDULE 13D](/filings/0001193125-26-226695.md) | Ownership report, active investor | 0001193125-26-226695 |
| 2026-05-15 | 18:58 ET | [SCHEDULE 13D](/filings/0000950103-26-007273.md) | Ownership report, active investor | 0000950103-26-007273 |
| 2026-05-11 | 20:30 ET | [8-K](/filings/0001193125-26-216899.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-26-216899 |
| 2026-05-04 | 10:05 ET | [S-1/A](/filings/0001193125-26-202398.md) | Registration statement, amended | 0001193125-26-202398 |
| 2026-04-17 | 20:05 ET | [S-1](/filings/0001193125-26-161514.md) | Registration statement | 0001193125-26-161514 |
| 2025-01-17 | 20:06 ET | [S-1](/filings/0001193125-25-008362.md) | Registration statement | 0001193125-25-008362 |

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:16 ET. No prices; not investment advice.